Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

v3.5.0.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2016
Fair Value Disclosures [Abstract]  
Financial assets and liabilities carried at fair value

The following tables set forth the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as follows (in thousands):

 

 

 

Fair Value Measurements at June 30, 2016 Using

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

 

 

Significant Other

Observable

Inputs

 

 

Significant

Unobservable

Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (1)

 

$

28,132

 

 

$

 

 

$

 

 

$

28,132

 

Marketable securities

 

 

442

 

 

 

 

 

 

 

 

 

442

 

 

 

$

28,574

 

 

$

 

 

$

 

 

$

28,574

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent warrant liabilities

 

$

 

 

$

 

 

$

269

 

 

$

269

 

 

 

 

Fair Value Measurements at December 31, 2015 Using

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

 

 

Significant Other

Observable

Inputs

 

 

Significant

Unobservable

Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (1)

 

$

42,590

 

 

$

 

 

$

 

 

$

42,590

 

Marketable securities

 

 

496

 

 

 

 

 

 

 

 

 

496

 

Total

 

$

43,086

 

 

$

 

 

$

 

 

$

43,086

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent warrant liabilities

 

$

 

 

$

 

 

$

10,464

 

 

$

10,464

 

 

(1)

Included in cash and cash equivalents

Warrant liabilities fair value assumptions

The estimated fair value of the contingent warrant liabilities was calculated using the following range of assumptions at June 30, 2016, and December 31, 2015:

 

 

 

June 30,

 

December 31,

 

 

2016

 

2015

Expected volatility

 

78% - 100%

 

166% - 183%

Risk-free interest rate

 

0.28% - 0.41%

 

0.64% - 0.74%

Expected term

 

0.44 - 0.69

 

0.94 - 1.19

 

Summary of changes in estimated fair value of Level 3 financial liabilities

The following table provides a summary of changes in the estimated fair value of the Company’s Level 3 financial liabilities for the six months ended June 30, 2016 (in thousands):

 

Balance at December 31, 2015

 

$

10,464

 

Decrease in estimated fair value of contingent warrant liabilities upon revaluation

 

 

(10,195

)

Balance at June 30, 2016

 

$

269

 

 

Outstanding debt carrying amount and estimated fair value

The carrying amount and the estimated fair value of the Company’s outstanding interest-bearing obligations at June 30, 2016, and December 31, 2015, are as follows (in thousands):

 

 

 

June 30, 2016

 

 

December 31, 2015

 

 

 

Carrying Amount

 

 

Estimated Fair Value

 

 

Carrying Amount

 

 

Estimated Fair Value

 

Hercules term loan

 

$

20,052

 

 

$

21,225

 

 

$

19,653

 

 

$

21,231

 

Novartis note

 

 

13,879

 

 

 

13,641

 

 

 

13,683

 

 

 

13,394

 

Servier loan

 

 

12,593

 

 

 

12,556

 

 

 

15,331

 

 

 

15,185

 

Total

 

$

46,524

 

 

$

47,422

 

 

$

48,667

 

 

$

49,810